{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T14:44:37Z","timestamp":1772808277701,"version":"3.50.1"},"reference-count":34,"publisher":"Scientific Scholar","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Dermatol Venereol Leprol"],"published-print":{"date-parts":[[2017]]},"DOI":"10.4103\/0378-6323.199422","type":"journal-article","created":{"date-parts":[[2017,2,3]],"date-time":"2017-02-03T02:16:10Z","timestamp":1486088170000},"page":"183","source":"Crossref","is-referenced-by-count":8,"title":["Association of protein tyrosine phosphatase, non-receptor type 22 +1858C\u2192T polymorphism and susceptibility to vitiligo: Systematic review and meta-analysis"],"prefix":"10.25259","volume":"83","author":[{"given":"Harish","family":"Changotra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silky","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10894","reference":[{"key":"key-10.4103\/0378-6323.199422-1","first-page":"526","volume-title":"Vitiligo: Pathomechanisms and genetic polymorphism of susceptible genes","author":"Shajil","year":"2006","journal-title":"Indian J Exp Biol"},{"key":"key-10.4103\/0378-6323.199422-2","first-page":"160","volume-title":"Clinical practice.Vitiligo","author":"Ta\u00efeb","year":"2009","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0378-6323.199422-3","first-page":"162","volume-title":"Vitiligo: A part of a systemic autoimmune process","author":"Gopal","year":"2007","journal-title":"Indian J Dermatol Venereol Leprol","ISSN":"https:\/\/id.crossref.org\/issn\/0378-6323","issn-type":"print"},{"key":"key-10.4103\/0378-6323.199422-4","first-page":"35","volume-title":"Autoantibodies against tyrosine hydroxylase in patients with non-segmental (generalised) vitiligo","author":"Kemp","year":"2011","journal-title":"Exp Dermatol"},{"key":"key-10.4103\/0378-6323.199422-5","first-page":"333","volume-title":"Autoantibodies to human melanocyte-specific protein pmel17 in the sera of vitiligo patients: A sensitive and quantitative radioimmunoassay (RIA)","author":"Kemp","year":"1998","journal-title":"Clin Exp Immunol"},{"key":"key-10.4103\/0378-6323.199422-6","first-page":"798","volume-title":"Autoantibodies to tyrosinase-related protein-1 detected in the sera of vitiligo patients using a quantitative radiobinding assay","author":"Kemp","year":"1998","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/0378-6323.199422-7","first-page":"942","volume-title":"Treatment of vitiligo vulgaris with narrow-band UVB and oral Polypodium leucotomos extract: A randomized double-blind placebo-controlled study","author":"Middelkamp-Hup","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"key-10.4103\/0378-6323.199422-8","first-page":"179","volume-title":"Clinical characteristics and PTPN22 1858C\/T variant analysis in Jordanian Arab vitiligo patients","author":"Alkhateeb","year":"2010","journal-title":"Mol Diagn Ther"},{"key":"key-10.4103\/0378-6323.199422-9","first-page":"300","volume-title":"Early disease onset and increased risk of other autoimmune diseases in familial generalized vitiligo","author":"Laberge","year":"2005","journal-title":"Pigment Cell Res"},{"key":"key-10.4103\/0378-6323.199422-10","first-page":"461","volume-title":"Vitiligo \u2013 Part 1","author":"Tarl\u00e9","year":"2014","journal-title":"An Bras Dermatol"},{"key":"key-10.4103\/0378-6323.199422-11","first-page":"271","volume-title":"The genetics of generalized vitiligo and associated autoimmune diseases","author":"Spritz","year":"2007","journal-title":"Pigment Cell Res"},{"key":"key-10.4103\/0378-6323.199422-12","first-page":"33","volume-title":"Liver X Receptor-a polymorphisms (rs11039155 and rs2279238) are associated with susceptibility to vitiligo","author":"Agarwal","year":"2016","journal-title":"Meta Gene"},{"key":"key-10.4103\/0378-6323.199422-13","first-page":"3689","volume-title":"Why is PTPN22 a good candidate susceptibility gene for autoimmune disease?","author":"Burn","year":"2011","journal-title":"FEBS Lett"},{"key":"key-10.4103\/0378-6323.199422-14","first-page":"453","volume-title":"Protein tyrosine phosphatase PTPN22 in human autoimmunity","author":"Vang","year":"2007","journal-title":"Autoimmunity"},{"key":"key-10.4103\/0378-6323.199422-15","first-page":"111","volume-title":"Cooperative inhibition of T-cell antigen receptor signaling by a complex between a kinase and a phosphatase","author":"Cloutier","year":"1999","journal-title":"J Exp Med"},{"key":"key-10.4103\/0378-6323.199422-16","first-page":"337","volume-title":"A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes","author":"Bottini","year":"2004","journal-title":"Nat Genet"},{"key":"key-10.4103\/0378-6323.199422-17","first-page":"5862","volume-title":"The codon 620 tryptophan allele of the lymphoid tyrosine phosphatase (LYP) gene is a major determinant of Graves' disease","author":"Velaga","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.4103\/0378-6323.199422-18","first-page":"504","volume-title":"Genetic association of the R620W polymorphism of protein tyrosine phosphatase PTPN22 with human SLE","author":"Kyogoku","year":"2004","journal-title":"Am J Hum Genet"},{"key":"key-10.4103\/0378-6323.199422-19","first-page":"330","volume-title":"A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis","author":"Begovich","year":"2004","journal-title":"Am J Hum Genet"},{"key":"key-10.4103\/0378-6323.199422-20","first-page":"404","volume-title":"Association of the PTPN22*R620W polymorphism with autoimmune myasthenia gravis","author":"Vandiedonck","year":"2006","journal-title":"Ann Neurol"},{"key":"key-10.4103\/0378-6323.199422-21","first-page":"977","volume-title":"Mutation screening of PTPN22: Association of the 1858T-allele with Addison's disease","author":"Skinningsrud","year":"2008","journal-title":"Eur J Hum Genet"},{"key":"key-10.4103\/0378-6323.199422-22","first-page":"88","volume-title":"Lack of association between PTPN22 Gene +1858 C\u2192T polymorphism and susceptibility to generalized vitiligo in a Turkish population","author":"Akbas","year":"2014","journal-title":"Ann Dermatol"},{"key":"key-10.4103\/0378-6323.199422-23","first-page":"584","volume-title":"A single-nucleotide polymorphism in the gene encoding lymphoid protein tyrosine phosphatase (PTPN22) confers susceptibility to generalised vitiligo","author":"Cant\u00f3n","year":"2005","journal-title":"Genes Immun"},{"key":"key-10.4103\/0378-6323.199422-24","first-page":"1433","volume-title":"Protein tyrosine phosphatase PTPN22 +1858C\/T polymorphism is associated with active vitiligo","author":"Garcia-Melendez","year":"2014","journal-title":"Exp Ther Med"},{"key":"key-10.4103\/0378-6323.199422-25","first-page":"1686","volume-title":"Variant of TYR and autoimmunity susceptibility loci in generalized vitiligo","author":"Jin","year":"2010","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0378-6323.199422-26","first-page":"206","volume-title":"The PTPN22-1858C\u2192T (R620W) functional polymorphism is associated with generalized vitiligo in the Romanian population","author":"Laberge","year":"2008","journal-title":"Pigment Cell Melanoma Res"},{"key":"key-10.4103\/0378-6323.199422-27","first-page":"260","volume-title":"Association of PTPN22 1858C\/T polymorphism with vitiligo susceptibility in Gujarat population","author":"Laddha","year":"2008","journal-title":"J Dermatol Sci"},{"key":"key-10.4103\/0378-6323.199422-28","first-page":"1539","volume-title":"Quantifying heterogeneity in a meta-analysis","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"key":"key-10.4103\/0378-6323.199422-29","first-page":"719","volume-title":"Statistical aspects of the analysis of data from retrospective studies of disease","author":"Mantel","year":"1959","journal-title":"J Natl Cancer Inst"},{"key":"key-10.4103\/0378-6323.199422-30","first-page":"177","volume-title":"Meta-analysis in clinical trials","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"key-10.4103\/0378-6323.199422-31","first-page":"691","volume-title":"The association of PTPN22 rs2476601 polymorphism and CTLA-4 rs231775 polymorphism with LADA risks: A systematic review and meta-analysis","author":"Dong","year":"2014","journal-title":"Acta Diabetol"},{"key":"key-10.4103\/0378-6323.199422-32","first-page":"49","volume-title":"The PTPN22 C1858T functional polymorphism and autoimmune diseases \u2013 A meta-analysis","author":"Lee","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"key-10.4103\/0378-6323.199422-33","first-page":"208","volume-title":"Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families","author":"Alkhateeb","year":"2003","journal-title":"Pigment Cell Res"},{"key":"key-10.4103\/0378-6323.199422-34","first-page":"2985","volume-title":"The CTLA-4+49 A\/G, CT60 A\/G and PTPN22 1858 C\/T polymorphisms and susceptibility to vitiligo: A meta-analysis","author":"Song","year":"2013","journal-title":"Mol Biol Rep"}],"container-title":["Indian Journal of Dermatology, Venereology, and Leprology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T05:43:47Z","timestamp":1611899027000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijdvl.com\/association-of-protein-tyrosine-phosphatase-non-receptor-type-22-1858ct-polymorphism-and-susceptibility-to-vitiligo-systematic-review-and-meta-analysis\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017]]}},"alternative-id":["199422"],"URL":"https:\/\/doi.org\/10.4103\/0378-6323.199422","relation":{},"ISSN":["0378-6323"],"issn-type":[{"value":"0378-6323","type":"print"}],"subject":[],"published":{"date-parts":[[2017]]}}}